Secondary Logo

Journal Logo

November/December 2017 - Volume 63 - Issue 6
pp: 693-853,e71-e81

Melding a High-Risk Patient for Continuous Flow Left Ventricular Assist Device into a Low-Risk Patient

Amione-Guerra, Javier; Cruz-Solbes, Ana S.; Gonzalez Bonilla, Hilda; More

ASAIO Journal. 63(6):704-712, November/December 2017.

Combined Therapy of Ventricular Assist Device and Membrane Oxygenator for Profound Acute Cardiopulmonary Failure

Fujita, Kevin; Takeda, Koji; Li, Boyangzi; More

ASAIO Journal. 63(6):713-719, November/December 2017.

Warfarin and Aspirin Versus Warfarin Alone for Prevention of Embolic Events in Patients with a HeartMate II Left Ventricular Assist Device

Van Tuyl, Joseph S.; Hollis, Ian B.; Alburikan, Khalid A.; More

ASAIO Journal. 63(6):731-735, November/December 2017.

Adverse Event Rates Change Favorably Over Time for Patients Bridged With the HeartWare Left Ventricular Assist Device

Maltais, Simon; Aaronson, Keith D.; Teuteberg, Jeffrey J.; More

ASAIO Journal. 63(6):745-751, November/December 2017.

Anticoagulation Control in Patients With Ventricular Assist Devices

Boehme, Amelia K.; Pamboukian, Salpy V.; George, James F.; More

ASAIO Journal. 63(6):759-765, November/December 2017.

Normothermic Ex Vivo Heart Perfusion: Effects of Live Animal Blood and Plasma Cross Circulation

Church, Joseph T.; Alghanem, Fares; Deatrick, Kristopher B.; More

ASAIO Journal. 63(6):766-773, November/December 2017.